Trials / Conditions / Metastatic Solid Malignancies
Metastatic Solid Malignancies
4 registered clinical trials studyying Metastatic Solid Malignancies.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Phase I Dose Escalation Study of Selinexor Plus Nivolumab and Ipilimumab in Advanced/Metastatic Solid Malign NCT04850755 | National University Hospital, Singapore | Phase 1 |
| Withdrawn | Consolidation Therapy in Patients With Metastatic Solid Malignancies NCT02705703 | Kiromic BioPharma Inc. | Phase 1 / Phase 2 |
| Completed | ⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma NCT03107663 | ImaginAb, Inc. | Phase 1 |
| Withdrawn | Effects of LBM and PPIs on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Patients NCT02439723 | AHS Cancer Control Alberta | Phase 1 |